Joseph She joined FOx Biosystems in September 2019 as Chief Operating Officer. He is an experienced life science professional with a proven track record in surface chemistry and assay development. He started his career at Biocartis in 2009, where he was part of the core team to develop the Dynamic Multi-Analyte Test (DMAT) technology. He was responsible for the optimization of the surface chemistry process of the encoded microparticles, and demonstrated a wide range of protein assays on the proprietary platform, Evalution. With the incorporation of MyCartis, a spin-off of Biocartis, in 2014, he was appointed Director of Assay Development and continued to play a pivotal role in further developing the DMAT technology and Evalution platform in the immunodiagnostic space. From 2017 to 2019, he was Director of Science and Technology and was responsible for managing external collaborations.
Joseph was an undergraduate at the University of Southampton and graduated with an MChem degree in Chemistry with Computer Science in 2005. He studied for a Ph.D. in surface chemistry and multiplexing technology at the same university under the supervision of Professor Peter L. Roach and Prof. Hywel Morgen.
Get in touch: